logo

Adverum Biotechnologies Inc. (ADVM)



Trade ADVM now with
  Date
  Headline
1/6/2019 8:03:32 PM Adverum Biotechnologies Expects This Quarter-end Cash Position To Fund Operations At Least Through H1 Of 2020
12/3/2018 4:25:03 PM Adverum Biotechnologies Appoints Mike Fitzgerald As VP, Human Resources
11/19/2018 8:38:36 AM Adverum Says First Patient Dosed In OPTIC Phase 1 Trial Of ADVM-022 Gene Therapy
10/17/2018 4:27:00 PM Adverum Biotechnologies Appoints Leone Patterson As CEO And Director
8/24/2018 8:33:49 AM Adverum Biotechnologies Gets Orphan Drug Designation For ADVM-053; Plans To Submit IND In Q4
7/24/2018 4:03:58 PM Adverum Biotechnologies Appoints Katherine Bock As VP, Investor Relations & Corporate Communications
5/9/2018 4:15:18 PM Adverum Biotechnologies Q1 Loss/share $0.30 Vs. Loss $0.38 Year Ago
5/3/2018 4:41:47 PM Adverum Biotechnologies: President And CEO Amber Salzman Make Mutual Determination To Step Down
3/6/2018 4:04:47 PM Adverum Biotechnologies Q4 Loss/share $0.32 Vs. Loss $0.54 Year Ago
2/26/2018 9:05:08 AM Adverum Completes Dosing Of First Cohort Of Patients In ADVANCE Phase 1/2 Clinical Trial Of ADVM-043 Gene Therapy
2/8/2018 8:10:31 AM Adverum Biotechnologies Announces Pricing Of $60 Mln Public Offering Of Common Stock